Compare Stocks: PETV, APYX, CNXU, and ECOR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.96 +4.6%	$3.33	$1.89 ▼ $5.08	$124.69M	1.31	88,294 shs	131,399 shs
CNXU Conexeu Sciences	$3.89 -1.8%	$6.96	$3.82 ▼ $18.79	$109.72M	N/A	208,091 shs	111,197 shs
ECOR electroCore	$11.12 -2.0%	$8.96	$4.41 ▼ $12.70	$100.26M	1	82,233 shs	52,223 shs
PETV PetVivo	$0.84 -0.1%	$0.70	$0.59 ▼ $1.69	$31.87M	1.36	10,703 shs	8,258 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-3.27%	-1.33%	-34.22%	+44.39%
CNXU Conexeu Sciences	0.00%	-21.57%	-44.74%	-64.51%	+388,999,900.00%
ECOR electroCore	0.00%	-4.79%	+14.52%	+41.84%	+115.92%
PETV PetVivo	0.00%	+7.17%	+23.38%	-1.29%	-18.54%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.96 +4.6%	$3.33	$1.89 ▼ $5.08	$124.69M	1.31	88,294 shs	131,399 shs
CNXU Conexeu Sciences	$3.89 -1.8%	$6.96	$3.82 ▼ $18.79	$109.72M	N/A	208,091 shs	111,197 shs
ECOR electroCore	$11.12 -2.0%	$8.96	$4.41 ▼ $12.70	$100.26M	1	82,233 shs	52,223 shs
PETV PetVivo	$0.84 -0.1%	$0.70	$0.59 ▼ $1.69	$31.87M	1.36	10,703 shs	8,258 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-3.27%	-1.33%	-34.22%	+44.39%
CNXU Conexeu Sciences	0.00%	-21.57%	-44.74%	-64.51%	+388,999,900.00%
ECOR electroCore	0.00%	-4.79%	+14.52%	+41.84%	+115.92%
PETV PetVivo	0.00%	+7.17%	+23.38%	-1.29%	-18.54%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.71	Moderate Buy	$6.60	122.97% Upside
CNXU Conexeu Sciences	2.00	Hold	$20.00	414.14% Upside
ECOR electroCore	2.00	Hold	$18.00	61.87% Upside
PETV PetVivo	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest PETV, APYX, CNXU, and ECOR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/21/2026	APYX Apyx Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/21/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/17/2026	CNXU Conexeu Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
7/14/2026	APYX Apyx Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/13/2026	APYX Apyx Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$7.00
6/29/2026	CNXU Conexeu Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 9/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$52.84M	2.36	N/A	N/A	$0.39 per share	7.59
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	$32.03M	3.13	N/A	N/A	($0.21) per share	-52.95
PETV PetVivo	$1.05M	30.47	N/A	N/A	($0.03) per share	-27.97

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$11.21M	-$0.20	N/A	N/A	N/A	-14.78%	-76.60%	-13.91%	11/5/2026 (Estimated)
CNXU Conexeu Sciences	-$3.92M	-$0.40	N/A	N/A	N/A	N/A	-200.20%	-177.26%	N/A
ECOR electroCore	-$13.97M	-$1.66	N/A	N/A	N/A	-39.96%	-1,956.38%	-81.35%	11/4/2026 (Estimated)
PETV PetVivo	-$10.95M	-$0.34	N/A	N/A	N/A	-902.82%	-4,813.07%	-281.78%	11/12/2026 (Estimated)

Latest PETV, APYX, CNXU, and ECOR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/14/2026	Q3 2026	CNXU Conexeu Sciences	-$0.10	-$0.29	-$0.19	-$0.29	N/A	N/A
8/6/2026	Q2 2026	APYX Apyx Medical	-$0.0820	-$0.07	+$0.0120	-$0.07	$13.18 million	$13.88 million
8/6/2026	Q2 2026	ECOR electroCore	-$0.4218	-$0.33	+$0.0918	-$0.33	$9.49 million	$9.45 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
PETV PetVivo	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	3.19	5.68	4.53
CNXU Conexeu Sciences	N/A	5.31	5.31
ECOR electroCore	N/A	1.21	1.00
PETV PetVivo	0.02	0.42	0.47

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
CNXU Conexeu Sciences	N/A
ECOR electroCore	26.74%
PETV PetVivo	24.55%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.90%
CNXU Conexeu Sciences	N/A
ECOR electroCore	7.80%
PETV PetVivo	10.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	205	42.12 million	35.43 million	Optionable
CNXU Conexeu Sciences	4	28.21 million	N/A	N/A
ECOR electroCore	83	9.02 million	8.31 million	Not Optionable
PETV PetVivo	20	37.98 million	19.06 million	Not Optionable

PETV, APYX, CNXU, and ECOR Headlines

Recent News About These Companies

PetVivo (NASDAQ:PETV) Stock Price Down 0.1% - Time to Sell?

September 26 at 2:01 AM | americanbankingnews.com

PetVivo : Michael Handley Joins PetVivo Holdings, Inc. Board of Directors

September 22, 2026 | marketscreener.comM

Jaime Pickett Joins PetVivo Holdings, Inc. Board of Directors

September 22, 2026 | globenewswire.com

Michael Handley Joins PetVivo Holdings, Inc. Board of Directors

September 22, 2026 | globenewswire.com

PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027

September 16, 2026 | globenewswire.com

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

September 8, 2026 | markets.businessinsider.com

PetVivo Holdings, Inc.: Petvivo Holdings Announces Name Change Of Human Subsidiary To Somatrix Technologies, Inc. And Expands Focus On Human Health Innovation

August 20, 2026 | finanznachrichten.de

PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION

August 20, 2026 | finance.yahoo.com

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 2026 FETCH KANSAS CITY VETERINARY CONFERENCE IN KANSAS CITY, MISSOURI

August 18, 2026 | jsonline.comJ

PetVivo Holdings, Inc.: PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

August 15, 2026 | finanznachrichten.de

PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

August 14, 2026 | globenewswire.com

PetVivo Holdings, Inc.: Petvivo Holdings Announces Termination And Settlement Agreement With Vetstem

July 29, 2026 | finanznachrichten.de

PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM

July 28, 2026 | globenewswire.com

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE TEVA SUMMER CE SYMPOSIUM AT HORSESHOE BAY RESORT, TEXAS

July 21, 2026 | oklahoman.comO

PetVivo Holdings Inc.

July 20, 2026 | marketwatch.com

PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

July 14, 2026 | globenewswire.com

PetVivo Holdings Inc (PETV) Q4 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges

July 2, 2026 | finance.yahoo.com

PetVivo Holdings, Inc.: PetVivo Reports Financial and Operational Results for Fiscal 2026

June 30, 2026 | finanznachrichten.de

PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript

June 29, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV, APYX, CNXU, and ECOR Company Descriptions

Apyx Medical NASDAQ:APYX

$2.96 +0.13 (+4.59%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$2.89 -0.07 (-2.23%)

As of 09/25/2026 07:34 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Conexeu Sciences NASDAQ:CNXU

$3.89 -0.07 (-1.77%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$3.86 -0.03 (-0.77%)

As of 09/25/2026 07:30 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

electroCore NASDAQ:ECOR

$11.12 -0.23 (-2.03%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$11.12 0.00 (-0.04%)

As of 09/25/2026 07:30 PM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

PetVivo NASDAQ:PETV

$0.84 0.00 (-0.12%)

As of 09/25/2026 02:52 PM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PETV, APYX, CNXU, and ECOR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PETV, APYX, CNXU, and ECOR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PETV, APYX, CNXU, and ECOR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV, APYX, CNXU, and ECOR Company Descriptions

Apyx Medical NASDAQ:APYX

Conexeu Sciences NASDAQ:CNXU

electroCore NASDAQ:ECOR

PetVivo NASDAQ:PETV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PETV, APYX, CNXU, and ECOR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PETV, APYX, CNXU, and ECOR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PETV, APYX, CNXU, and ECOR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV, APYX, CNXU, and ECOR Company Descriptions

Apyx Medical NASDAQ:APYX

Conexeu Sciences NASDAQ:CNXU

electroCore NASDAQ:ECOR

PetVivo NASDAQ:PETV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools